Summary statement: Utility of molecular marker testing in thyroid cancer

Linwah Yip, Electron Kebebew, Mira Milas, Sally E. Carty, Thomas J. Fahey, Sareh Parangi, Martha A. Zeiger, Yuri E. Nikiforov

    Research output: Contribution to journalArticle

    22 Scopus citations

    Abstract

    The use of molecular markers for thyroid cancer diagnosis, prognosis, and surveillance have been an exciting area of study and change. Recent investigative focus on promising new markers will very likely lead to improvements in the diagnostic utility of fine needle aspiration biopsy (FNAB) in predicting malignancy, as well as provide more accurate prognostic information pre- and postoperatively. The 2010 Annual Meeting of the American Association for Endocrine Surgeons featured a symposium dedicated to molecular marker testing in thyroid cancer and its potential clinical applicability.

    Original languageEnglish (US)
    Pages (from-to)1313-1315
    Number of pages3
    JournalSurgery
    Volume148
    Issue number6
    DOIs
    StatePublished - Dec 2010

    ASJC Scopus subject areas

    • Surgery

    Fingerprint Dive into the research topics of 'Summary statement: Utility of molecular marker testing in thyroid cancer'. Together they form a unique fingerprint.

  • Cite this

    Yip, L., Kebebew, E., Milas, M., Carty, S. E., Fahey, T. J., Parangi, S., Zeiger, M. A., & Nikiforov, Y. E. (2010). Summary statement: Utility of molecular marker testing in thyroid cancer. Surgery, 148(6), 1313-1315. https://doi.org/10.1016/j.surg.2010.09.023